Global Antidiabetics Market 2014 – 2020 Key Trends, Size, Share, Demand and Analysis by Syndicate Market Research

Syndicate Market Research releases a new market research report “Antidiabetics Market – Global Industry Perspective, Comprehensive Analysis, Size, Share, Segment, Trends and Forecast 2014 – 2020” to add to its collection of reports database.

Diabetes mellitus, commonly known as diabetes, is a group of metabolic diseases in which blood sugar levels goes extremely high over a prolonged period. Antidiabetics are the medicines developed to stabilize and control blood glucose (sugar) levels amongst diabetes patient. Antidiabetic drugs are generally used to control diabetes. Insulin pramlintide (Amylin), GLP-1 receptor agonists such as byetta and victoza are the different types of antidiabetics drugs. The global antidiabetics market is driven by increasing prevalence of diabetes mellitus.

Increasing disposable income has been resulted into significant changes in lifestyle. This in turn has been resulted into increasing incidences of disorders such as obesity which may cause the diabetes. This is primarily triggered the demand for antidiabetics. Additionally, advancement in pharmaceutical sector helps to drive the antidiabetics market. However, high cost of insulin is expected to be a major restraint of antidiabetics market. The market size and forecasts in terms of revenue (USD million) for the period 2015 to 2020, considering 2014 as the base year, have been provided for this segment of the report. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2015 to 2020.

Browse the full “Global Antidiabetics Market – Industry Perspective, Comprehensive Analysis, Size, Share, Trends, Segment and Forecast, 2014 – 2020” report at:

The report provides a comprehensive view on the antidiabetics; we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the antidiabetics market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate and general attractiveness.

The global antidiabetics market is segmented on the basis of product and region. The productsegments of the global antidiabetics market include insulin, rapid acting, long acting, premixed, premixed analog, short acting, intermediate acting, antidiabetics, alpha-glucosidase inhibitors, biguanides, sulphonylureas, glp-1 agonist, meglitinides, dpp-4 inhibitors, sglt – 2 and thiazolodinediones. Insulin dominated the overall market in terms of revenue.

Major regional segments analyzed in this study include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, further bifurcation of region on the country level, which include U.S., Germany, UK, France, China, Japan and India. North America dominated antidiabetics market.

Some of the key players for global antidiabetics market include Boehringer Ingelheim GmbH, Astra Zeneca plc, Eli Lilly & Co., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, SanofiS.A., Johnson & Johnson, Mankind Pharma Ltd., and Teva Pharmaceutical Industries Ltd.

Get Sample Research Reports at:

Key segments of the Global Antidiabetics Market

Global Antidiabetics Market:  Product Segment Analysis

  • Insulin
    • Rapid acting
    • Long acting
    • Premixed
    • Premixed analog
    • Short acting
    • Intermediate acting
    • Antidiabetics
    • Alpha-glucosidase inhibitors
  • Biguanides
    • Sulphonylureas
    • GLP-1 agonist
    • Meglitinides
    • DPP-4 inhibitors
    • SGLT – 2
    • Thiazolodinediones

Global Antidiabetics Market: Region Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia-Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East & Africa

Related Published Pharmaceuticals Reports:

About Us

Syndicate Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. SMR’s experienced team of Analysts, Researchers, and Consultants uses proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each SMR syndicated research report covers a different sector — such as pharmaceuticals, chemical, energy, food and beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports strive to serve the overall research requirement of clients.

Media Contact
Company Name: Syndicate Market Research
Contact Person: Joel John
Phone: +1-386-310 3803
Address:3422 SW 15 Street, Suit #8138
City: Deerfield Beach
State: FL
Country: United States